Skip to main content

Cholestasis clinical trials at UC Health
4 in progress, 2 open to new patients

  • A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease

    open to eligible people ages up to 18 years

    The purpose of the study is to investigate if intravenous fish oil, commercially available as Omegaven, safely and effectively reverses parenteral nutrition associated cholestasis in children.

    at UCLA

  • Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis

    open to eligible people ages up to 18 years

    This is a clinical study designed to evaluate the safety and benefit of a fish oil based fat emulsion in the treatment of liver disease associated with prolonged use of intravenous nutrition.

    at UCSD

  • FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

    Sorry, accepting new patients by invitation only

    Noninvasive monitoring of liver fibrosis is an unmet need within the clinical management of pediatric chronic liver disease. While liver biopsy is often used in the initial diagnostic evaluation, subsequent biopsies are rarely performed because of inherent invasiveness and risks. This study will evaluate the role of non-invasive FibroScan™ technology to detect and quantify liver fibrosis.

    at UCSF

  • PROBE: A Prospective Database of Infants With Cholestasis

    Sorry, not currently recruiting here

    Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary Atresia Research Consortium (BARC) is to establish a database of clinical information and serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal hepatitis (INH) to facilitate research and to perform clinical, epidemiological and therapeutic trials in these two important pediatric liver diseases.

    at UCSF

Last updated: